reference/4404333

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/4404333

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Historical Article\|Journal Article\|Multicenter Study\|Research Support, Non-U.S. Gov't
endingPage	28
issn	1537-6613 0022-1899
issueIdentifier	1
pageRange	20-28
publicationName	The Journal of Infectious Diseases
startingPage	20
bibliographicCitation	Cozzi-Lepri A, De Luca A, Phillips AN, Bongiovanni M, Di Giambenedetto S, Mena M, Moioli MC, Arlotti M, Sighinolfi L, Narciso P, Lichtner M, Cauda R, Monforte Ad; ICoNA Study Group; UCSC-Roma HIV Cohort Study Group; IMIT Study Group. A comparison between abacavir and efavirenz as the third drug used in combination with a background therapy regimen of 2 nucleoside reverse-transcriptase inhibitors in patients with initially suppressed viral loads. J Infect Dis. 2006 Jul 01;194(1):20–8. doi: 10.1086/504265. PMID: 16741878.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_773488fa326b4e0bd48bd21c4992715b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a9f26eef2bf249791b7c1ce817d24362 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2bca07bef44fdcd284b28c7d8135408e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_037d85abe8b3cfc4e547f6ceeeaa492e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f3dbbb77727ba136162a82db88bc5dc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_419d88827636bca3965b784a9a906d61 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7934f7082d9987aa6a5f1f421ed1cf96 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_43d6293e60de693f393a21c89fd53b34 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1498-4229 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8b2efc0ba4deccb17947be58cec632d1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c08bd53697d04e4861580fb22133322a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_895feb0752d26af3906d85ed5f3103f8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8aeae68905954cb2a8e768d37e45da2a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5210c092fb56fb204dfd6bafdab870b3
date	2006-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1086/504265 https://pubmed.ncbi.nlm.nih.gov/16741878
isPartOf	https://portal.issn.org/resource/ISSN/0022-1899 https://portal.issn.org/resource/ISSN/1537-6613 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4830
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	A Comparison between Abacavir and Efavirenz as the Third Drug Used in Combination with a Background Therapy Regimen of 2 Nucleoside Reverse‐Transcriptase Inhibitors in Patients with Initially Suppressed Viral Loads
discusses	http://id.nlm.nih.gov/mesh/M0023387 http://id.nlm.nih.gov/mesh/M0028255 http://id.nlm.nih.gov/mesh/M0012553 http://id.nlm.nih.gov/mesh/M0000724 http://id.nlm.nih.gov/mesh/M0277557 http://id.nlm.nih.gov/mesh/M0015639 http://id.nlm.nih.gov/mesh/M0005491 http://id.nlm.nih.gov/mesh/M0461882 http://id.nlm.nih.gov/mesh/M0258297
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D018894Q000627 http://id.nlm.nih.gov/mesh/D000163Q000188 http://id.nlm.nih.gov/mesh/D015224Q000627 http://id.nlm.nih.gov/mesh/D010078Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D008055Q000097 http://id.nlm.nih.gov/mesh/D000163Q000821 http://id.nlm.nih.gov/mesh/D003521 http://id.nlm.nih.gov/mesh/D013997 http://id.nlm.nih.gov/mesh/D000480 http://id.nlm.nih.gov/mesh/D011446 http://id.nlm.nih.gov/mesh/D004359 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D048588 http://id.nlm.nih.gov/mesh/D049674 http://id.nlm.nih.gov/mesh/D015331 http://id.nlm.nih.gov/mesh/D019562 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D005260
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID35370 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398739 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID462220 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18283 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64139 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60825 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441300

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128575040 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129722732

Total number of triples: 72.